ArticleHepatology communications2024

Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing.

Muhamuda Kader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.